Braak staging of Alzheimer's disease

From Aaushi
Jump to navigation Jump to search

Introduction

Braak & Braak define 2 separate staging criteria for neuropathologic staging of Alzheimer's disease.

Staging

staging based on PHF-tau pathology

Braak staging of Alzheimer's disease based upon histopathology of neurofibrillary tangles & neuropil threads in autopsy specimens.

The distribution & packing density of amyloid plaques varies widely & is of little significance for differentiation of neuropathologic stages.

6 stages distinguished by location & severity of changes see 'NFT & neuropil thread by stage & region (Braak & Braak)'

* microglial activation & PHF-tau propagate jointly across Braak stages[2]

staging based on beta-amyloid pathology

Most amyloid plaques are not associated with neurofibrillary changes & neurons within the amyloid appear normal.

In early stages of Alzheimer's disease, amyloid plaques show considerable variability in shape, size & quantity.

End-stage Alzheimer's disease shows a fairly consistent distribution pattern of amyloid plaques.

3 stages of amyloid deposition are described

More general terms

References

  1. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl). 1991;82(4):239-59. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/1759558
  2. 2.0 2.1 Pascoal TA, Benedet AL, Ashton NJ et al. Microglial activation and tau propagate jointly across Braak stages. Nat Med 2021. August 21 PMID: https://www.ncbi.nlm.nih.gov/pubmed/34446931 https://www.nature.com/articles/s41591-021-01456-w